Create a narrative

Glenmark Pharmaceuticals Community

NSEI:GLENMARK Community

1 Narratives written by author
0 Comments on narratives written by author
8 Fair Values set on narratives written by author

Create a narrative

Glenmark Pharmaceuticals

AN

AnalystConsensusTarget

Consensus Narrative from 12 Analysts

Upcoming Diabetes And Respiratory Launches To Expand Product Portfolio

Key Takeaways Growth in India's formulations, notably in dermatology and cardiac, and upcoming diabetes product launches are set to drive future revenue growth. Strategic partnerships and regulatory filings in oncology and respiratory sectors aim to bolster global position and revenue growth.

₹1.69k

FV

15.1% undervalued

8.40%

Revenue growth p.a.

0

0

4

7 days ago